Welcome to Francis Academic Press

The Frontiers of Society, Science and Technology, 2022, 4(9); doi: 10.25236/FSST.2022.040911.

Analysis of the Strategic Management of the Chinese Government in the R&D and Use of COVID-19 Vaccines


Yuyin Huang1, Na Li2

Corresponding Author:
Na Li

1Teaching Center, Ningbo Open University, Ningbo, China

2School of Law, Ningbo University, Ningbo, China


After the outbreak of COVID-19, the Chinese government quickly decided to develop vaccines. In terms of vaccine research and development, China has carried out strategic planning and management, including route selection, scientific research resource organization and mobilization, diversified research and development, and team research, and has introduced international cooperation to achieve results in the development of multiple vaccine varieties. China has accelerated construction and management optimization in the vaccine production industry chain, and formed a huge production capacity. With various technical means,the Chinese government helps promote universal vaccination, and rapidly completes the construction of an immune barrier. The Chinese government’s “going out” strategy for international cooperation in vaccines has played a role in the global fight against COVID-19.


vaccine, virus, immunization, strategy

Cite This Paper

Yuyin Huang, Na Li. Analysis of the Strategic Management of the Chinese Government in the R&D and Use of COVID-19 Vaccines. The Frontiers of Society, Science and Technology (2022) Vol. 4, Issue 9: 49-54. https://doi.org/10.25236/FSST.2022.040911.


[1] McDonnell, E . Implanting Strategic Management [M]. Prentice Hall, 1990.

[2] Venkatraman N, Camillus J. Exploring the Concept of "Fit" in Strategic Management.[J]. Academy of Management Review, 1984, 9(3):513-525.

[3] Silva F, Gomes L. Strategic Management of Technology and Innoviation[M]. McGraw-Hill, 1996.

[4] Meier K. Strategic Management and the Performance of Public Organizations: Testing Venerable Ideas against Recent Theories[J]. Journal of Public Administration Research and Theory: J-PART, 2007, 17(3):357-377.

[5] Teece D. Economic Analysis and Strategic Management[J]. California Management Review, 1984, 26(3):87-110.

[6] Postma T , Liebl F . How to Improve Scenario Analysis as a Strategic Management Tool?[J]. Technological Forecasting and Social Change, 2005, 72(2):161-173.

[7] Nutt P, Backoff R. Strategic Management of Public and Third Sector Organizations : a Handbook for Leaders[M]. Jossey-Bass Publishers, 1992.

[8] Ingram P, Silverman B. The New Institutionalism in Strategic Management[J]. Advances in Strategic Management, 2002, 19:1-30.

[9] Carpio C, Coman I, Sarasty O. COVID-19 Vaccine Demand and Financial Incentives[J]. Applied Health Economics and Health Policy, 2021, 19(6):871-883.

[10] Huang H , Huang H , Zhu X. COVID-19 Vaccine Uptake, Acceptance, and Hesitancy Among Persons With Mental Disorders During the Second Stage of China's Nationwide Vaccine Rollout[J]. Frontiers in Medicine, 2021, 8:2218.